Neoplastic Cells are a Rare Component in Human Glioblastoma Microvasculature

DSpace/Manakin Repository

Neoplastic Cells are a Rare Component in Human Glioblastoma Microvasculature

Citable link to this page

. . . . . .

Title: Neoplastic Cells are a Rare Component in Human Glioblastoma Microvasculature
Author: Rodriguez, Fausto J.; Orr, Brent A.; Eberhart, Charles G.; Ligon, Keith Lloyd

Note: Order does not necessarily reflect citation order of authors.

Citation: Rodriguez, Fausto J., Brent A. Orr, Keith L. Ligon, and Charles G. Eberhart. 2012. Neoplastic cells are a rare component in human glioblastoma microvasculature. Oncotarget 3(1): 98-106.
Full Text & Related Files:
Abstract: Microvascular proliferation is a key biological and diagnostic hallmark of human glioblastoma, one of the most aggressive forms of human cancer. It has recently been suggested that stem-like glioblastoma cells have the capacity to differentiate into functional endothelial cells, and that a significant proportion of the vascular lining in tumors has a neoplastic origin. In principle, this finding could significantly impact the efficacy and development of antiangiogenic therapies targeting the vasculature. While the potential of stem-like cancer cells to form endothelium in culture seems clear, in our clinical experience using a variety of molecular markers, neoplastic cells do not contribute significantly to the endothelial-lined vasculature of primary human glioblastoma. We sought to confirm this impression by analyzing vessels in glioblastoma previously examined using chromogenic in situ hybridization (CISH) for EGFR and immunohistochemistry for mutant IDH1. Vessels containing cells expressing these definitive neoplastic markers were identified in a small fraction of tumors, but only 10% of vessel profiles examined contained such cells and when identified these cells comprised less than 10% of the vascular cellularity in the cross section. Interestingly, these rare intravascular cells showing EGFR amplification by CISH or mutant IDH1 protein by immunohistochemistry were located in the middle or outer portions of vessel walls, but not amongst the morphologic boundaries of the endothelial lining. To more directly address the capacity of glioblastoma cells to contribute to the vascular endothelium, we performed double labeling (Immunofluorescence/FISH) for the endothelial marker CD34 and EGFR gene locus. Although rare CD34 positive neoplastic cells unassociated with vessels were identified (<1%), this analysis did not identify EGFR amplified cells within vascular linings, and further supports our observations that incorporation of glioblastoma cells into the tumor vessels is at best extremely rare, and therefore of questionable clinical or therapeutic significance.
Published Version: http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292896/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:8609126

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters